SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-17-008172
Filing Date
2017-02-14
Accepted
2017-02-14 06:12:00
Documents
1
Group Members
DAVID L. DOUGLASSDEEPIKA R. PAKIANATHAN, PH.D.DELPHI BIOINVESTMENTS VII, L.P.DELPHI MANAGEMENT PARTNERS VII, L.L.C.DOUGLAS A. ROEDERJAMES J. BOCHNOWSKI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A v458992_sc13ga.htm SC 13G/A 113837
  Complete submission text file 0001144204-17-008172.txt   115428
Mailing Address 160 BOVET RD, SUITE 408 SAN MATEO CA 94402
Business Address 160 BOVET RD, SUITE 408 SAN MATEO CA 94402 650-854-9650
DELPHI VENTURES VII L P (Filed by) CIK: 0001336922 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 650-421-9500
Relypsa Inc (Subject) CIK: 0001416792 (see all company filings)

IRS No.: 260893742 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87732 | Film No.: 17602181
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences